Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms.

Chang JW, Wei NC, Su HJ, Huang JL, Chen TC, Wu YC, Yu CT, Hou MM, Hsieh CH, Hsieh JJ, Wu CE, Cheng HY, Hsu T, Wang TH.

Anticancer Res. 2012 Apr;32(4):1259-65.

PMID:
22493357
2.

An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.

Roepman P, Jassem J, Smit EF, Muley T, Niklinski J, van de Velde T, Witteveen AT, Rzyman W, Floore A, Burgers S, Giaccone G, Meister M, Dienemann H, Skrzypski M, Kozlowski M, Mooi WJ, van Zandwijk N.

Clin Cancer Res. 2009 Jan 1;15(1):284-90. doi: 10.1158/1078-0432.CCR-08-1258.

3.

A five-gene signature and clinical outcome in non-small-cell lung cancer.

Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC.

N Engl J Med. 2007 Jan 4;356(1):11-20.

4.

Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.

Lee ES, Son DS, Kim SH, Lee J, Jo J, Han J, Kim H, Lee HJ, Choi HY, Jung Y, Park M, Lim YS, Kim K, Shim Y, Kim BC, Lee K, Huh N, Ko C, Park K, Lee JW, Choi YS, Kim J.

Clin Cancer Res. 2008 Nov 15;14(22):7397-404. doi: 10.1158/1078-0432.CCR-07-4937.

5.

Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.

Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.

J Pathol. 2006 Oct;210(2):192-204.

PMID:
16915569
6.

Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study.

Blackhall FH, Wigle DA, Jurisica I, Pintilie M, Liu N, Darling G, Johnston MR, Keshavjee S, Waddell T, Winton T, Shepherd FA, Tsao MS.

Lung Cancer. 2004 Nov;46(2):197-204.

PMID:
15474668
7.

Blood-based gene expression signatures in non-small cell lung cancer.

Zander T, Hofmann A, Staratschek-Jox A, Classen S, Debey-Pascher S, Maisel D, Ansén S, Hahn M, Beyer M, Thomas RK, Gathof B, Mauch C, Delank KS, Engel-Riedel W, Wichmann HE, Stoelben E, Schultze JL, Wolf J.

Clin Cancer Res. 2011 May 15;17(10):3360-7. doi: 10.1158/1078-0432.CCR-10-0533. Epub 2011 May 10.

8.

Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.

Oshita F, Ikehara M, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y.

J Exp Ther Oncol. 2004 Jul;4(2):155-60.

PMID:
15500010
9.

A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer.

Hsu YC, Yuan S, Chen HY, Yu SL, Liu CH, Hsu PY, Wu G, Lin CH, Chang GC, Li KC, Yang PC.

Clin Cancer Res. 2009 Dec 1;15(23):7309-15. doi: 10.1158/1078-0432.CCR-09-1572. Epub 2009 Nov 17.

10.

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

Patnaik SK, Kannisto E, Knudsen S, Yendamuri S.

Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22.

11.

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.

Lung Cancer. 2009 Mar;63(3):410-7. doi: 10.1016/j.lungcan.2008.06.003. Epub 2008 Jul 11.

PMID:
18620780
12.

Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.

Takada M, Tada M, Tamoto E, Kawakami A, Murakawa K, Shindoh G, Teramoto K, Matsunaga A, Komuro K, Kanai M, Fujiwara Y, Shirata K, Nishimura N, Miyamoto M, Okushiba S, Kondo S, Hamada J, Katoh H, Yoshiki T, Moriuchi T.

J Surg Res. 2004 Nov;122(1):61-9.

PMID:
15522316
13.

DNA methylation markers and early recurrence in stage I lung cancer.

Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG.

N Engl J Med. 2008 Mar 13;358(11):1118-28. doi: 10.1056/NEJMoa0706550.

14.

Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.

Hofmann HS, Bartling B, Simm A, Murray R, Aziz N, Hansen G, Silber RE, Burdach S.

Oncol Rep. 2006 Sep;16(3):587-95.

PMID:
16865260
15.

HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.

Tan D, Deeb G, Wang J, Slocum HK, Winston J, Wiseman S, Beck A, Sait S, Anderson T, Nwogu C, Ramnath N, Loewen G.

Diagn Mol Pathol. 2003 Dec;12(4):201-11.

PMID:
14639106
16.

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.

Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K, Kawakami Y.

Cancer. 1995 Dec 15;76(12):2457-63.

17.

A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.

Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.

J Natl Cancer Inst. 2006 Jun 21;98(12):825-38.

PMID:
16788156
18.

Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.

Wigle DA, Jurisica I, Radulovich N, Pintilie M, Rossant J, Liu N, Lu C, Woodgett J, Seiden I, Johnston M, Keshavjee S, Darling G, Winton T, Breitkreutz BJ, Jorgenson P, Tyers M, Shepherd FA, Tsao MS.

Cancer Res. 2002 Jun 1;62(11):3005-8.

19.

Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer.

Dingemans AM, van den Boogaart V, Vosse BA, van Suylen RJ, Griffioen AW, Thijssen VL.

Mol Cancer. 2010 Jun 17;9:152. doi: 10.1186/1476-4598-9-152.

20.

A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.

Yanagisawa K, Tomida S, Shimada Y, Yatabe Y, Mitsudomi T, Takahashi T.

J Natl Cancer Inst. 2007 Jun 6;99(11):858-67.

PMID:
17551146

Supplemental Content

Support Center